Siddiqui Mohammad Rizwan, Moorthy Krishnan, Taha Asia, Hussain Mohd Ejaz, Baquer Najma Zaheer
Hormone and Drug Research Laboratory, School of Life Sciences, Jawaharlal Nehru University, New Delhi, 110067, India.
Mol Cell Biochem. 2006 Apr;285(1-2):17-27. doi: 10.1007/s11010-005-9002-9. Epub 2006 Apr 19.
Oral administration of vanadate to diabetic animals have been shown to stabilize the glucose homeostasis and restore altered metabolic pathways. However, vanadate exerts these effects at relatively high doses with several toxic effects. Low doses of vanadate are relatively safe but unable to elicit any antidiabetic effects. The present study explored the prospect of using low doses of vanadate with Trigonella foenum graecum, seed powder (TSP), another antidiabetic agent, and to evaluate their antidiabetic effect in diabetic rats. Alloxan diabetic rats were treated with insulin, vanadate, TSP and low doses of vanadate with TSP for three weeks. The effect of these antidiabetic compounds was examined on general physiological parameters, Na(+)/K(+) ATPase activity, membrane lipid peroxidation and membrane fluidity in liver, kidney and heart tissues. Expression of glucose transporter (GLUT4) protein was also examined by immunoblotting method in experimental rat heart after three weeks of diabetes induction. Diabetic rats showed high blood glucose levels. Activity of Na(+)/K(+) ATPase decreased in diabetic liver and heart. However, kidney showed a significant increase in Na(+)/K(+) ATPase activity. Diabetic rats exhibited an increased level of lipid peroxidation and decreased membrane fluidity. GLUT4 distribution was also significantly lowered in heart of alloxan diabetic rats. Treatment of diabetic rats with insulin, TSP, vanadate and a combined therapy of lower dose of vanadate with TSP revived normoglycemia and restored the altered level of Na(+)/K(+) ATPase, lipid peroxidation and membrane fluidity and also induced the redistribution of GLUT4 transporter. TSP treatment alone is partially effective in restoring the above diabetes-induced alterations. Combined therapy of vanadate and TSP was the most effective in normalization of altered membrane linked functions and GLUT4 distribution without any harmful side effect.
已证明给糖尿病动物口服钒酸盐可稳定葡萄糖稳态并恢复改变的代谢途径。然而,钒酸盐在相对高剂量时发挥这些作用,同时伴有多种毒性作用。低剂量的钒酸盐相对安全,但无法产生任何抗糖尿病作用。本研究探索了将低剂量钒酸盐与另一种抗糖尿病药物胡芦巴种子粉(TSP)联合使用的前景,并评估它们对糖尿病大鼠的抗糖尿病作用。用胰岛素、钒酸盐、TSP以及低剂量钒酸盐与TSP对四氧嘧啶糖尿病大鼠进行为期三周的治疗。检测了这些抗糖尿病化合物对一般生理参数、肝、肾和心脏组织中Na(+)/K(+) ATP酶活性、膜脂质过氧化和膜流动性的影响。还通过免疫印迹法检测了糖尿病诱导三周后实验大鼠心脏中葡萄糖转运蛋白(GLUT4)的表达。糖尿病大鼠血糖水平较高。糖尿病肝脏和心脏中Na(+)/K(+) ATP酶活性降低。然而,肾脏中Na(+)/K(+) ATP酶活性显著增加。糖尿病大鼠脂质过氧化水平升高,膜流动性降低。四氧嘧啶糖尿病大鼠心脏中GLUT4分布也显著降低。用胰岛素、TSP、钒酸盐以及低剂量钒酸盐与TSP联合治疗糖尿病大鼠可恢复正常血糖水平,恢复Na(+)/K(+) ATP酶、脂质过氧化和膜流动性的改变水平,并诱导GLUT4转运蛋白的重新分布。单独使用TSP治疗在恢复上述糖尿病诱导的改变方面部分有效。钒酸盐和TSP联合治疗在使改变的膜相关功能和GLUT4分布正常化方面最有效,且无任何有害副作用。